Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13
Acute myeloid leukemia patients with FMS-like tyrosine kinase 3–internal tandem duplications and mixed lineage leukemia–protein AF9 fusion proteins suffer from poor clinical outcomes. The MOLM-13 acute myeloid leukemia cell line harbors both of these abnormalities and is used in CRISPR experiments t...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2022-03-01
|
| Col·lecció: | BioTechniques |
| Matèries: | |
| Accés en línia: | https://www.future-science.com/doi/10.2144/btn-2021-0089 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|